• ์ „ํ•ด์งˆ์ด ์†Œ๋ณ€์—์„œ ์–ผ๋งˆ๋‚˜ ๋น ์ ธ๋‚˜๊ฐ”๋Š”์ง€ ํ™•์ธํ•˜๋Š” ์ง€ํ‘œ. (net result of tubular reabsorption & secretion)
  • ์ˆ˜์น˜ ์ฆ๊ฐ€ = ์ „ํ•ด์งˆ ๋งŽ์ด ๋น ์ ธ๋‚˜๊ฐ = ์„ธ๋‡จ๊ด€ ์žฌํก์ˆ˜, ๋ถ„๋น„์— ์ด์ƒ ์žˆ์Œ
  • ํŠน์ • ์ „ํ•ด์งˆ๊ณผ creatinine์„ ์†Œ๋ณ€ ๋ฐ ํ˜ˆ์žฅ์—์„œ ์ธก์ • ํ›„ ๊ณต์‹์— ๋Œ€์ž…
  • ์ผ๋ณ„, ์‹œ๊ฐ„๋Œ€๋ณ„, ํ™˜์ž๋ณ„๋กœ ๊ฐ€๋ณ€์  โ†’ ํ•œ ๋ฒˆ ์ธก์ •์œผ๋กœ๋Š” ์ •ํ™•๋„ ๋–จ์–ด์ง, ์ž„์ƒ์  ํ™œ์šฉ๋„ ๋‚ฎ์Œ

FC sodium

  • pre-renal azotemia์™€ intrinsic renal failure๋ฅผ ๊ตฌ๋ถ„.
  • AKI(acute kidney injury)์—์„œ ํšŒ๋ณต์— ๋Œ€ํ•œ prognostic marker.

FC potassium

  • hypokalemia (์ €์นผ๋ฅจํ˜ˆ์ฆ)์˜ renal / non-renal ์›์ธ์„ ๊ตฌ๋ถ„.

FC phosphate

  • CKD ํ™˜์ž์—์„œ ์ธ ์ œํ•œ(phosphate restriction)์ด ์ž˜ ๋˜์—ˆ๋Š”์ง€ (์‹์ด์ ์œผ๋กœ, ๋˜๋Š” ์ธ ํก์ฐฉ์ œ ํ™œ์šฉ ์‹œ)
  • โ†’ ์น˜๋ฃŒ ๋ฐ˜์‘ ํ‰๊ฐ€์— ์œ ์šฉ